Agilent, 883995-906, ZORBAX StableBond 300 C8, 4.6 x 150 mm, 5 µm

ZORBAX StableBond 300 C8, 4.6 x 150 mm, 5 µm. A reversed-phase C8 HPLC column with fully porous ZORBAX particles. StableBond technology ensures stability at low pH.

Specifications:
Brand: ZORBAX 300SB-C8
Hardware: SS
Inner Diameter (ID): 4.6 mm
LC Platform: Stainless Steel
Length: 150 mm
Maximum Temperature: 80 °C
Part Number Application Domain: Biopharma
Part Number Application: Monoclonal Antibodies (mABs)PeptidesProteins
Particle Size: 5 µm
Particle Type: Fully Porous
Phase: 300SB-C8
Pore Size: 300 Å
Pressure Rating: 400 bar
Separation Mode: Reversed Phase
Shipping Solvent: Acetonitrile/Water
Technique: LCLC & LC/MS
UNSPSC Code: 41115709
pH Range: 1-8

**********The following product description is generated by AI and is for reference only. If you have any questions, please contact customer service.**********
Engineered for robust performance in high-performance liquid chromatography, this reversed-phase column features a durable C8 bonded phase on a 300 angstrom pore silica, ideal for separating large biomolecules such as peptides, proteins, and other biologics. Measuring 4.6 mm internal diameter by 150 mm length with a 5 micron particle size, it offers a balanced blend of resolution, throughput, and loading capacity for demanding analytical and preparative workflows. Its StableBond technology ensures exceptional column lifetime, even under low pH mobile phases, supporting consistent results in routine and advanced research applications within pharmaceutical, biotechnology, and academic laboratories. The 300 angstrom pore size enhances mass transfer and maintains peak performance for higher molecular weight analytes. This column is fully compatible with a wide range of Agilent 1100, 1200, and 1260 Infinity LC systems, as well as other industry-standard HPLC instruments. It pairs seamlessly with other ZORBAX columns for method development or scale-up, and is suited for use with both conventional and UHPLC setups. Applications include peptide mapping, intact protein analysis, and the characterization of recombinant biologics, providing reliable and reproducible results for critical bioanalytical studies.